about
Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptorEndoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancerRegulation of trophoblast beta1-integrin expression by contact with endothelial cellsMolecular Imaging of Angiogenesis in Cardiac RegenerationInteraction of human osteoblast-like Saos-2 and MG-63 cells with thermally oxidized surfaces of a titanium-niobium alloyAcute cellular rejection following human heart transplantation is associated with increased expression of vitronectin receptor (integrin alphavbeta3)Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and functionEvaluation of Tc-99m-3PRGD2 Integrin Receptor Imaging in the Differential Diagnosis of Breast Lesions and Comparison With Mammography.Protein structure prediction and biomolecular recognition: from protein sequence to peptidomimetic design with the human beta3 integrin.Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubblesDisease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis.Determining glioma response to radiation therapy using recombinant peptides.Peptide-based probes for targeted molecular imaging.Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation.Peptides and peptide hormones for molecular imaging and disease diagnosisCoordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseInvolvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells.Autoradiography screening of potential positron emission tomography tracers for asymptomatic abdominal aortic aneurysmsMolecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles.alpha(v)beta(3) Integrin antagonists as inhibitors of bone resorption.99mTc-3P4-RGD2 scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review)FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in CisRadiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECTA new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging.Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates.Vitronectin expression in the airways of subjects with asthma and chronic obstructive pulmonary disease.The type II collagen N-propeptide, PIIBNP, inhibits cell survival and bone resorption of osteoclasts via integrin-mediated signaling.Orally active αvβ3 integrin inhibitor MK-0429 reduces melanoma metastasisSubstance P mediates antiapoptotic responses in human colonocytes by Akt activationPET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides.Multicomponent dipeptide hydrogels as extracellular matrix-mimetic scaffolds for cell culture applications.(68)Ga-Labeling of RGD peptides and biodistributionStroma targeting nuclear imaging and radiopharmaceuticals.Human umbilical mesenchymal stem cells conditioned medium promote primary wound healing regeneration.Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.(99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.
P2860
Q24301712-78B24D92-5B50-4DE4-AF67-4FA6F7B75223Q24531949-E8243AC0-4B63-483B-BF86-9B8252C78420Q24535009-33EA895D-C85F-4D47-B33F-5F6E0C6A0496Q24650026-5E4120B2-CED4-47A5-A470-50405E8326D0Q24796713-B239A388-577D-4EDA-836C-45712658FE8AQ28073273-4CD2DBCB-E326-434B-A59E-34F534A2CF48Q28540174-64E4C8F0-2D07-479B-BF37-3CECC4F98F7DQ28592958-25D4F93A-7A34-412C-9DB1-96955CE8DF53Q28593115-5A36ACF9-1BF5-4AC9-8509-87FBBA89EFD3Q30274889-F873A45C-3574-4D25-98E2-3B84100D74D0Q30331577-3005C95B-2078-44EA-A105-05CC60DE7132Q30499622-0AD0DADF-C7D2-4E69-AAC1-FB801B63558DQ32044975-A24A72E2-FD89-4507-AB82-64F56C886706Q33382467-4B1B8F57-063D-48EB-8FBC-F701AFD39C2BQ33526620-B3505FAB-FA77-425B-86DB-81D4512DC53DQ33836004-D15150A7-9500-4D18-9515-073ED8FCDA23Q33846924-1C1510FB-067F-4D66-813E-0079EC738B6DQ33870879-8DE523FD-EAE1-4475-B20E-6A4CE6C9D15EQ33946698-1173F48D-0235-428C-A0E7-F9BFBBFFEBF4Q33978492-C2FEB098-71C0-4DE8-A78D-937020822436Q34033191-9C400811-047D-4EAC-8BD3-72F08DAFAAB2Q34074902-9E17340C-7211-48F7-9D67-AB9B9B44C016Q34252825-74EC285D-66AA-4710-B8D3-C033807E9AA5Q34433546-E7EF8C43-C980-4F3F-820D-F1BBFFF47269Q34556242-2E47D05B-0285-47D1-8367-850307876D3BQ34758185-704BA799-85B4-46EE-A7AF-0CC342BE649EQ34912643-1968D590-E06E-43AB-8E5E-E8D1BC6B529BQ35009658-BA1E4D3A-6131-4DF8-AD25-AC02E811E4FDQ35148491-0BFF5A7B-1A11-4A59-9215-F342F29B2ED7Q35175185-B21FDD86-1F44-404A-9294-E0FE94111E15Q35196305-C198B368-6CA1-457E-A3ED-0488D932D056Q35605710-D5AC0B80-1B91-469E-9F21-2947748FADF7Q35629395-7A1494FB-1A00-4BB3-B401-FCE08573B5A7Q35641937-820D9CE5-E054-4E14-89F4-0F65BC2134BAQ35846920-8311E1C4-35D3-4298-BBA5-9FA766936D00Q35929628-286920DB-A42C-4F30-B387-C976A001C202Q35999606-1F37337F-CCDD-4CBD-9743-CB378E5CF52DQ36072383-5EFB6C49-10D1-4199-AC5A-9F232866E26CQ36348748-37CD4002-F0C0-480D-9D63-3CC32FF125C6Q36511837-CD9BD605-7B67-4D6E-B476-609684256661
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The alpha v beta 3 integrin "vitronectin receptor"
@ast
The alpha v beta 3 integrin "vitronectin receptor"
@en
The alpha v beta 3 integrin "vitronectin receptor"
@nl
type
label
The alpha v beta 3 integrin "vitronectin receptor"
@ast
The alpha v beta 3 integrin "vitronectin receptor"
@en
The alpha v beta 3 integrin "vitronectin receptor"
@nl
prefLabel
The alpha v beta 3 integrin "vitronectin receptor"
@ast
The alpha v beta 3 integrin "vitronectin receptor"
@en
The alpha v beta 3 integrin "vitronectin receptor"
@nl
P3181
P1476
The alpha v beta 3 integrin "vitronectin receptor"
@en
P2093
M A Horton
P3181
P356
10.1016/S1357-2725(96)00155-0
P407
P577
1997-05-01T00:00:00Z